谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial

Fred Saad,Andrew J. Armstrong,Mototsugu Oya,Karina Vianna,Mustafa Ozguroglu,Craig Gedye,Gary L. Buchschacher Jr,Ji Youl Lee,Urban Emmenegger,Jiri Navratil,Juan Antonio Virizuela,Anibal Salazar,Denis Maillet,Hiroji Uemura,Jeri Kim,Emma Oscroft,Laura Barker,Arnold Degboe,Noel W. Clarke

EUROPEAN UROLOGY ONCOLOGY（2024）

引用 0|浏览41
关键词
Abiraterone,Metastatic castration-resistant prostate cancer,Olaparib,PROpel,Tolerability
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要